Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleImatinib—Neuartige, molekulare Therapiemöglichkeit bei chronischer myeloischer Leukämie.AuthorsBerger, U.; Hehlmann, R.PublicationDer Internist, 2004, Vol 45, Issue 1, p102ISSN0020-9554Publication typeArticleDOI10.1007/s00108-003-1085-3